Inovio Pharmaceuticals (INO) Debt Ratio (2010 - 2026)

Inovio Pharmaceuticals has disclosed Debt Ratio across 17 years of filings, most recently posting 0.51 for Q2 2026.

• In Q2 2026, Debt Ratio rose 202.76% year-over-year to 0.51; the TTM figure through Jun 2026 stood at 0.51 (up 202.76% YoY), while the FY2025 annual figure was 0.39, up 234.05% from the prior year.
• Debt Ratio came in at 0.51 for Q2 2026 at Inovio Pharmaceuticals, up from 0.5 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.73 in Q3 2025 to a low of 0.0 in Q2 2022.
• Average Debt Ratio over 5 years is 0.19, with a median of 0.1 recorded in 2023.
• Year-over-year, Debt Ratio decreased 2.77% in 2022 and surged 2701.6% in 2023.
• Over 5 years, Debt Ratio stood at 0.0 in 2022, then surged by 2701.6% to 0.1 in 2023, then grew by 19.36% to 0.12 in 2024, then jumped by 234.05% to 0.39 in 2025, then climbed by 29.53% to 0.51 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.51 in Q2 2026, 0.5 in Q1 2026, and 0.39 in Q4 2025.